Skip to main content
PRIMR23 SBER23 Main banner
Icon Legend
Presentation Icons
Pre-Reg Required
Pre-Reg Required
Additional Fee
Additional Fee
Livestreaming Session Icon
Livestreaming Session Icon
Live Session Recorded
Live Session Recorded
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
CPIA Accredited
CPIA Accredited
Call for Session Proposal
Call for Session Proposal
Human Subjects Research
Human Subjects Research
IACUC/Animal Care and Use
IACUC/Animal Care and Use
Crossover
Crossover
Institutional Leadership
Institutional Leadership
Workshop Series
Workshop Series
Thought Leader Series
Thought Leader Series
Deep Dive Series
Deep Dive Series
Learning Lab Series
Learning Lab Series
Networking Series
Networking Series
Vendor Insight Series
Vendor Insight Series
Pillars of PRIM&R Poster Award
Pillars of PRIM&R Poster Award
Poster Icons
Record Session Icon
Record Session Icon
Pre-Reg Required
Pre-Reg Required
Part I/II
Part I/II
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
Prerecorded Session Icon
Prerecorded Session Icon
CIP Accredited
CIP Accredited
Pillars Icon
Pillars Icon
Back

2023 PRIM&R Annual Conference

Pharma/Biotech Perspectives

Emerging Research Challenges and Breaking Issues

Research Conducted in the Digital World

D11 - [IN-PERSON ONLY] Translating Ethical Principles for the Responsible Use of Emerging Science and Technology Across a Global Pharmaceutical Company

Tuesday, December 5, 2023
1:00 PM – 2:00 PM ET
Location: Room 149 AB
Human Subjects Research Call for Session Proposal Deep Dive Series CIP Accredited
This session is being held in-person only at PRIMR23. It will not be recorded for on-demand access or for the PRIMR23/SBER23 Virtual Meeting.

The biopharmaceutical industry understands that their work impacts people in a fundamental way--with regard to their health and when they are at their most vulnerable. Given the rapid evolution of emerging science and technology and the speed at which legislation, regulation, and guidance governing these are developed, it is critical to have ethical decision-making frameworks that are available for use and embedded throughout the medicine lifecycle--from drug discovery and development to product distribution and patient care. This session will take a deep dive into a collaborative approach to responsible innovation and review specific case studies that demonstrate how it is evolving biomedical ethics toward a model that requires multi-stakeholder, cross-functional engagements.

Learning Objectives:

  • Learn how to collaboratively develop ethical principles and frameworks for the responsible use of emerging science and technology, specifically in the areas of sharing and reusing health data as well as the responsible use of Artificial Intelligence (AI)
  • Understand how the organizational approach and application of data and AI ethical principles has been foundational to responsible innovation in drug discovery, drug development, product distribution through to patient care
  • Gain experience applying these principles to relevant cases and learn to identify questions and build best practices for being transparent and managing this ethically complex space together